Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Hemopoietic stem cell transplant for multiple myeloma (MM).

Barlogie B.

Leukemia. 1993 Jul;7(7):1095. No abstract available.

PMID:
8100602
[PubMed - indexed for MEDLINE]
2.

The role of autologous blood stem cells in support of high-dose therapy for multiple myeloma.

Fermand JP, Chevret S, Levy Y, Miclea JM, Tsapis A, Gerota J, Benbunan M, Brouet JC.

Hematol Oncol Clin North Am. 1992 Apr;6(2):451-62. Review.

PMID:
1349886
[PubMed - indexed for MEDLINE]
3.

The current status of hematopoietic stem cell transplantation for multiple myeloma.

Bensinger WI.

Clin Adv Hematol Oncol. 2004 Jan;2(1):46-52. Review.

PMID:
16163159
[PubMed - indexed for MEDLINE]
4.

The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.

Kyle RA.

Ann Oncol. 2000;11 Suppl 1:55-8. Review.

PMID:
10707780
[PubMed - indexed for MEDLINE]
5.

A case of multiple myeloma possibly cured by autologous blood stem cell transplantation.

Park HM, Lee MH, Nahm CH, Kim WC, Lee HB, Kim CS.

Intern Med J. 2010 Apr;40(4):314-5. doi: 10.1111/j.1445-5994.2009.02157.x. No abstract available.

PMID:
20529044
[PubMed - indexed for MEDLINE]
6.

[Auto-hematopoietic stem cell transplantation for multiple myeloma accompanied with amyloidosis in four limbs].

Song HH, Chen BA, Ding JH, Gao C, Tao YQ, Wang J, Wang J, Zhao G, Sun YY, Cheng J, Bao W.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):770-3. Chinese.

PMID:
19549405
[PubMed - indexed for MEDLINE]
7.

Impact of the conditioning regimen in patients with multiple myeloma who undergo autologous transplantation.

de la Rubia J, Lahuerta JJ.

J Clin Oncol. 2011 May 20;29(15):e449; author reply e450. doi: 10.1200/JCO.2010.33.7832. Epub 2011 Apr 11. No abstract available.

PMID:
21482988
[PubMed - indexed for MEDLINE]
Free Article
8.

[Autograft of hematopoietic stem cells in multiple myeloma].

Harousseau JL.

Presse Med. 2003 Jul 12;32(24):1107. French. No abstract available.

PMID:
12947736
[PubMed - indexed for MEDLINE]
9.

[Hemopoietic stem cell transplantation for multiple myeloma-review].

Chen WM.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Aug;12(4):546-52. Review. Chinese.

PMID:
15363153
[PubMed - indexed for MEDLINE]
10.

Long-term follow-up of tandem autologous stem-cell transplantation in multiple myeloma.

Regelink JC, van Roessel CH, van Galen KP, Ossenkoppele GJ, Huijgens PC, Zweegman S.

J Clin Oncol. 2010 Dec 10;28(35):e741-3; author reply e744-5. doi: 10.1200/JCO.2010.31.5515. Epub 2010 Nov 8. No abstract available.

PMID:
21060027
[PubMed - indexed for MEDLINE]
Free Article
11.

Update on the treatment of multiple myeloma.

Kyle RA.

Oncologist. 2001;6(2):119-24. Review.

PMID:
11306723
[PubMed - indexed for MEDLINE]
Free Article
12.

Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.

Mehta J.

J Natl Cancer Inst. 2009 Oct 21;101(20):1430-1; author reply 1431-3. doi: 10.1093/jnci/djp320. Epub 2009 Sep 30. No abstract available.

PMID:
19794130
[PubMed - indexed for MEDLINE]
Free Article
13.

Hemopoietic stem cell transplants for multiple myeloma.

Jagannath S, Vesole DH, Tricot G, Crowley J, Salmon SE, Barlogie B.

Oncology (Williston Park). 1994 Nov;8(11):89-103; discussion 103-6. Review.

PMID:
7826841
[PubMed - indexed for MEDLINE]
14.

Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.

Tricot G, Kern SE, Barlogie B.

J Natl Cancer Inst. 2009 Jul 1;101(13):964-6; author reply 966-7. doi: 10.1093/jnci/djp127. Epub 2009 Jun 17. No abstract available.

PMID:
19535776
[PubMed - indexed for MEDLINE]
Free Article
15.

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.

Cavo M, Tacchetti P, Patriarca F, Petrucci MT, Pantani L, Galli M, Di Raimondo F, Crippa C, Zamagni E, Palumbo A, Offidani M, Corradini P, Narni F, Spadano A, Pescosta N, Deliliers GL, Ledda A, Cellini C, Caravita T, Tosi P, Baccarani M; GIMEMA Italian Myeloma Network.

Lancet. 2010 Dec 18;376(9758):2075-85. doi: 10.1016/S0140-6736(10)61424-9. Epub 2010 Dec 9. Erratum in: Lancet. 2011 Nov 26;378(9806):1846.

PMID:
21146205
[PubMed - indexed for MEDLINE]
16.

[Treatment of multiple myeloma with peripheral blood stem cell transplantation].

Fujii H, Nakagawa H.

Nihon Rinsho. 1995 Mar;53(3):664-70. Review. Japanese.

PMID:
7699902
[PubMed - indexed for MEDLINE]
17.

Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma.

Thompson PA, Prince HM, Seymour JF, Ritchie D, Stokes K, Burbury K, Wolf M, Peinert S, Joyce T, Harrison SJ.

Bone Marrow Transplant. 2011 May;46(5):764-5. doi: 10.1038/bmt.2010.180. Epub 2010 Aug 2. No abstract available.

PMID:
20676149
[PubMed - indexed for MEDLINE]
18.

Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myeloma.

Beaven AW, Moore DT, Sharf A, Serody JS, Shea TC, Gabriel DA.

Cancer Invest. 2011 Mar;29(3):214-9. doi: 10.3109/07357907.2010.550663.

PMID:
21314330
[PubMed - indexed for MEDLINE]
19.

[Preparation of concentrated grafts of healthy CD34 hematopoietic stem cells and performance of autografts in hematology].

Gorin NC, Lopez M, Douay L, Laporte JP, Lesage S, Stachowiack J, Isnard F, Najman A.

Nouv Rev Fr Hematol. 1993 Jun;35(3):287-9. French. No abstract available.

PMID:
7687774
[PubMed - indexed for MEDLINE]
20.

Current trends in autologous stem-cell transplantation for myeloma in the era of novel therapies.

Moreau P, Avet-Loiseau H, Harousseau JL, Attal M.

J Clin Oncol. 2011 May 10;29(14):1898-906. doi: 10.1200/JCO.2010.32.5878. Epub 2011 Apr 11. Review.

PMID:
21482979
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk